Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069742 · ClinicalTrials.gov registry record · NA
Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting
A NA study of Breast Neoplasm, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT03069742: Completed NA study of Breast Neoplasm, sponsored by Columbia University.
NCT03069742 is a NA study of Breast Neoplasm that has completed, run by Columbia University. The registered enrollment target is 300 participants, above the 151-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (99% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03069742, a NA study of Breast Neoplasm, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized controlled trial (RCT) is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer prevention options. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigators hypothesize that improving accuracy of breast cancer risk perception and understanding of the risks and benefits of breast cancer risk lowering drugs, also known as chemoprevention, will increase the uptake of chemoprevention in the primary care setting.
Primary Outcome
The primary endpoint is to determine the uptake rate of a SERM or AI medication for breast cancer chemoprevention at 6 months (after the next primary care visit) in the active arm compared to usual care (control arm). Electronic health records will be used to track chemoprevention uptake after exposure to the intervention, the RealRisks decision aid, or the control, standard standard breast health education brochures.
Conditions Studied
Interventions
- OTHER RealRisks
- OTHER BNAV
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-08 |
| Phase | NA |
What the finished NCT03069742 record still lists
NCT03069742 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 151-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (99% higher).
The record links to 1 condition, with Breast Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which RealRisks is the first listed.
NCT03069742 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03069742 about?
NCT03069742 is a clinical study titled "Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting". The purpose of this randomized controlled trial (RCT) is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer prevention options. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care set...
What is the current status of trial NCT03069742?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-11. Estimated completion is 2022-08.
What conditions does trial NCT03069742 study?
This clinical trial studies the following conditions: Breast Neoplasm.
What interventions are being tested in trial NCT03069742?
The interventions under investigation include: RealRisks (OTHER), BNAV (OTHER).
Who is sponsoring clinical trial NCT03069742?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03069742 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03069742's enrollment target sits among peer trials
300 5th of 26 higher than 22 of 26 other Breast Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
RECRUITING · NA
-
Cryoablation vs Lumpectomy in T1 Breast Cancers
RECRUITING · NA
-
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
RECRUITING · NA
-
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
ACTIVE NOT RECRUITING · NA
-
Post-treatment Care of Breast Cancer Survivors
COMPLETED · NA
-
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia